<DOC>
	<DOCNO>NCT02209909</DOCNO>
	<brief_summary>Platelet activation pump coronary artery bypass ( OPCAB ) surgery may affect thrombus formation . The purpose study assess effect preoperative continuation aspirin platelet activation pump coronary artery bypass surgery .</brief_summary>
	<brief_title>Effects Low Dose Aspirin Pre-treatment Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery</brief_title>
	<detailed_description>Patients undergo OPCAB surgery randomize continue preoperative aspirin discontinue aspirin surgery . Platelet activation evaluate measure platelet p-selectin use flowcytometry . In study , compare platelet-activated marker conventional coagulation test .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>age : 2080 elective OPCAB inform consent coagulation disorder emergency operation , reoperation coexist valvular disease le 6 month cerebral vascular accident heparin induce thrombocytopenia heparin resistance menstrual phase preoperative cardiopulmonary bypass , continuous venoveno hemofiltration , intraaortic balloon pump application le 12 month myocardiac infarction le 10 day unstable angina less 30 day percutaneous coronary intervention le 6 wks bare metal stent insertion le 12 month drug elute stent insertion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>preoperative aspirin use</keyword>
	<keyword>platelet activation</keyword>
	<keyword>pump coronary artery bypass</keyword>
</DOC>